BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2
20 results:

  • 1. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FGF signalling facilitates cervical cancer progression.
    Mahmood HA; Tomas Bort E; Walker AJ; Grose RP; Chioni AM
    FEBS J; 2022 Jun; 289(12):3440-3456. PubMed ID: 34951738
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risk factors associated with the persistence of human papillomavirus after cervical excision in patients with high-grade squamous intra-epithelial neoplasia.
    Zang L; Huang J; Zhu J; Hu Y
    Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():175-181. PubMed ID: 34689015
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High-sensitivity C-reactive Protein and Regression of Low-grade Squamous Intraepithelial Lesion: The Role of Low-grade Inflammation in Cervical Carcinogenesis.
    Ahn S; Kim GJ; Do SI; Kim K; Lee H; Do IG; Kim DH; Chae SW; Ryu S; Sohn JH
    J Epidemiol; 2021 Dec; 31(12):615-620. PubMed ID: 33536377
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. fgfr4 promotes nuclear localization of GABP to inhibit cell apoptosis in uterine leiomyosarcoma.
    Zhang P; Zhang H; Wang Y
    Cell Tissue Res; 2021 Feb; 383(2):865-879. PubMed ID: 33151453
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
    Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
    Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.
    Park E; Kim SW; Kim S; Kim HS; Lee JY; Kim YT; Cho NH
    Mod Pathol; 2021 Mar; 34(3):637-646. PubMed ID: 32641744
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.
    Gallagher CS; Mäkinen N; Harris HR; Rahmioglu N; Uimari O; Cook JP; Shigesi N; Ferreira T; Velez-Edwards DR; Edwards TL; Mortlock S; Ruhioglu Z; Day F; Becker CM; Karhunen V; Martikainen H; Järvelin MR; Cantor RM; Ridker PM; Terry KL; Buring JE; Gordon SD; Medland SE; Montgomery GW; Nyholt DR; Hinds DA; Tung JY; ; Perry JRB; Lind PA; Painter JN; Martin NG; Morris AP; Chasman DI; Missmer SA; Zondervan KT; Morton CC
    Nat Commun; 2019 Oct; 10(1):4857. PubMed ID: 31649266
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FGFR Signaling as a Candidate Therapeutic Target for cancers Resistant to Carbon Ion Radiotherapy.
    Darwis NDM; Nachankar A; Sasaki Y; Matsui T; Noda SE; Murata K; Tamaki T; Ando K; Okonogi N; Shiba S; Irie D; Kaminuma T; Kumazawa T; Anakura M; Yamashita S; Hirakawa T; Kakoti S; Hirota Y; Tokino T; Iwase A; Ohno T; Shibata A; Oike T; Nakano T
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540114
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing.
    Mas A; Alonso R; Garrido-Gómez T; Escorcia P; Montero B; Jiménez-Almazán J; Martín J; Pellicer N; Monleón J; Simón C
    Am J Obstet Gynecol; 2019 Oct; 221(4):320.e1-320.e23. PubMed ID: 31121144
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Study on the Association between the Fibroblast Growth Factor Receptor 4 Expression and High-Risk Human Papillomavirus Infection in Cervical cancer and Precancerous Lesions.
    Guo L; Zhao A; Zhang R; Xie Y; Xu X
    Gynecol Obstet Invest; 2018; 83(6):608-614. PubMed ID: 29982249
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.
    Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A
    Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of uterine Cervical cancer and Patient Prognosis.
    Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH
    Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Iriomoteolides-9a and 11a: two new odd-numbered macrolides from the marine dinoflagellate Amphidinium species.
    Kumagai K; Tsuda M; Fukushi E; Kawabata J; Masuda A; Tsuda M
    J Nat Med; 2017 Jul; 71(3):506-512. PubMed ID: 28255848
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.
    Choi CH; Chung JY; Kim JH; Kim BG; Hewitt SM
    J Transl Med; 2016 May; 14(1):124. PubMed ID: 27154171
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations.
    Kim DH; Kwak Y; Kim ND; Sim T
    Cancer Biol Ther; 2016; 17(1):65-78. PubMed ID: 26574622
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
    Skinner SR; Szarewski A; Romanowski B; Garland SM; Lazcano-Ponce E; Salmerón J; Del Rosario-Raymundo MR; Verheijen RH; Quek SC; da Silva DP; Kitchener H; Fong KL; Bouchard C; Money DM; Ilancheran A; Cruickshank ME; Levin MJ; Chatterjee A; Stapleton JT; Martens M; Quint W; David MP; Meric D; Hardt K; Descamps D; Geeraerts B; Struyf F; Dubin G;
    Lancet; 2014 Dec; 384(9961):2213-27. PubMed ID: 25189358
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. FGF receptors: cancer biology and therapeutics.
    Katoh M; Nakagama H
    Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Ovarian metastasis and other ovarian neoplasms in women with cervical cancer stage IA-IIA.
    Ngamcherttakul V; Ruengkhachorn I
    Asian Pac J Cancer Prev; 2012; 13(9):4525-9. PubMed ID: 23167373
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Amplification of fgfr4 gene in human breast and gynecological cancers.
    Jaakkola S; Salmikangas P; Nylund S; Partanen J; Armstrong E; Pyrhönen S; Lehtovirta P; Nevanlinna H
    Int J Cancer; 1993 May; 54(3):378-82. PubMed ID: 8099571
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.